Eradication therapy in Helicobacter pylori positive peptic ulcer disease: Systematic review and economic analysis

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1833-1855

  Ford, Alexander C ^b   Delaney, Brendan C ^b   Forman, David ^b   Moayyedi, Paul ^a  

^a CITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; BISMUTH SALICYLATE; CLARITHROMYCIN; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; NIZATIDINE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; SUCRALFATE; TETRACYCLINE; TINIDAZOLE;

CLINICAL TRIAL; CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; DATA BASE; DUODENUM ULCER; ECONOMIC EVALUATION; ERADICATION THERAPY; EVALUATION; HELICOBACTER PYLORI; HUMAN; MEDICAL LITERATURE; MONTE CARLO METHOD; PEPTIC ULCER; PRIORITY JOURNAL; PROBABILITY; RECURRENT DISEASE; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GASTRIC MUCOSA; HEALTH CARE COSTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 4544263657     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40014.x     Document Type: Review

References (77)

1. Penston JG. Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharm Ther 1996;10:469-86.
2. Imperiale TF, Speroff T, Cebul RD, et al. A cost analysis of alternative treatments for duodenal ulcer. Ann Int Med 1995;123:665-72.
3. Talley NJ, Silverstein MD, Agreus L, et al. AGA technical review: Evaluation of dyspepsia. Gastroenterology 1998;114:582-95.
4. O'Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: An introduction to statistical issues and methods. Statistical Methods in Medical Research 2002;11:455-68.
5. Ford AC, Delaney BC, Forman D, et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. (Protocol for a Cochrane Review). Cochrane Database Syst Rev 2003.
6. Asaka M, Sugiyama T, Kato M, et al. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter 2001;6:254-61.
7. Avsar E, Kalayci C, Tozun N, et al. Refractory duodenal ulcer healing and relapse: Comparison of omeprazole with Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 1996;8:449-52.
8. Axon AT, O'Morain CA, Bardhan KD, et al. Randomized double-blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br Med J 1997;314:565-8.
9. Bardhan KD, Dallaire C, Eisold H, et al. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. Gut 1997;41:181-6.
10. Bayerdorffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:697-702.
11. Bayerdorffer E, Miehlke S, Mannes GA, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995;108:1412-7.
12. Bayerdorffer E, Miehlke S, Lehn N, et al. Cure of gastric ulcer disease after cure of Helicobacter pylori infection-German Gastric Ulcer Study. Eur J Gastroenterol Hepatol 1996;8:343-9.
13. Carpintero P, Blanco M, Pajares JM. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer. Clin Infect Dis 1997;25:1032-7.
14. Chen TS, Tsay SH, Chang FY, et al. Triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse: Comparison of 1 week and 2 week regimens and recrudescence rates over 12 months. J Gastroenterol Hepatol 1995;10:300-5.
15. Figueroa G, Acuna R, Troncoso M, et al. Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients. Am J Gastroenterol 1996;91:1395-9.
16. Fukuda Y, Yamamoto I, Okui M, et al. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7(Suppl 1):S45-S47.
17. Fukuda Y, Yamamoto I, Okui M, et al. Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients. J Clin Gastroenterol 1995;20(Suppl 2):S132-S135.
18. Furuta T, Futami H, Arai H, et al. Effects of lansoprazole with or without amoxicillin on ulcer healing: Relation to eradication of Helicobacter pylori. J Clin Gastroenterol 1995;20(Suppl 2):S107-S111.
19. Graham DY, Lew GM, Evans DG, et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med 1991;115:266-9.
20. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
21. Graham DY, Breiter JR, Ciociola AA, et al. and the RBC H. pylori Study Group. An alternative non-macrolide, non-imidazole treatment regimen for curing Helicobacter pylori and duodenal ulcers: Ranitidine bismuth citrate plus amoxicillin. Helicobacter 1998;3:125-131.
22. Harford W, Lanza F, Arora A, et al. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Helicobacter 1996;1:243-50.
23. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
24. Higuchi K, Fujiwara Y, Tominaga K, et al. Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled prospective study. Aliment Pharm Ther 2003;17:111-7.
25. Hosking SW, Ling TK, Yung MY, et al. Randomized controlled trial of short-term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992;305:502-4.
26. Kato M, Asaka M, Kudo M, et al. Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients. Aliment Pharm Ther 1996;10:821-7.
27. Katoh M, Asaka M, Kudoh M, et al. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori. J Clin Gastroenterol 1995;20(Suppl 2):S112-S114.
28. Kepekci Y, Kadayifci A. Does the eradication of Helicobacter pylori cure duodenal ulcer disease in communities with a high prevalence rate? Comparison with long-term acid suppression. Int J Clin Pract 1999;53:505-8.
29. Kim JS, Kim SG, Choi IJ, et al. Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer. Aliment Pharm Ther 2002;16:275-80.
30. Lam S-K, Ching C-K, Lai K-C, et al. Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomized double blind placebo controlled study. Gut 1997;41:43-8.
31. Lazzaroni M, Perego M, Bargiggia S, et al. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: A two-year, double-blind, placebo controlled study. Ital J Gastroenterol Hepatol 1997;29:220-7.
32. Lin JT, Wang JT, Wu MS, et al. Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori. J Formos Med Assoc 1994;93:368-73.
33. Logan RP, Bardhan KD, Celestin LR, et al. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: A randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment Pharm Ther 1995;9:417-23.
34. Malfertheiner P, Bayerdorffer E, Diete U, et al. The GUMACH study: The effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharm Ther 1999;13:703-12.
35. Mantzaris GJ, Hatzis A, Tamvakologos G, et al. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates. Dig Dis Sci 1993;38:1132-6.
36. Meining A, Hochter W, Weingart J, et al. and the Ulcer Study Group, Germany. Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. Scand J Gastroenterol 1998;33:49-54.
37. Miehlke S, Bayerdorffer E, Lehn N, et al. Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin. Digestion 1995;56:187-93.
38. Mones J, Rodrigo L, Sancho F, et al. Helicobacter pylori eradication versus one-year maintenance therapy: Effect on relapse and gastritis outcome. Rev Esp Enferm Dig 2001;93:381-9.
39. O'Morain C, Dettmer A, Rambow A, et al. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. Helicobacter 1996;1:130-7.
40. Parente F, Maconi G, Bargiggia S, et al. Comparison of two lansoprazole-antibiotic combinations (amoxycillin or classical triple therapy) for treatment of H. pylori infection in duodenal ulcer patients. Aliment Pharm Ther 1996;10:211-3.
41. Pinero R, Pacheco M, Urrestarazu M, et al. Helicobacter pylori eradication heals the duodenal ulcer. Randomized, simple, and controlled study with omeprazole. Rev Socied Venez Gastroenterol 1995;49:111-5.
42. Porro GB, Parente F, Lazzaroni M. Short and long-term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralphate alone. Gut 1993;34:466-9.
43. Porro GB, Lazzaroni M, Bargiggia S, et al. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. Am J Gastroenterol 1996;91:695-700.
44. Pounder RE, Wyeth JW, Duggan AE, et al. Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing. Helicobacter 1997;2:132-9.
45. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233-5.
46. Schwartz H, Krause R, Sahba B, et al. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: A randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Am J Gastroenterol 1998;93:584-90.
47. Shirotani T, Okada M, Murayama H, et al. Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: Randomized controlled study in Japan. J Gastroenterol 1996;31:175-81.
48. Sobhani I, Chastang C, de Korwin J-D, et al. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence: Results of a multicentric double-blind randomized trial. Gastroenterol Clin Biol 1995;19:252-8.
49. Spinzi GC, Sangiovanni A, Imperiali G, et al. Prevention of duodenal ulcer relapse with amoxycillin and omeprazole. Eur J Gastroenterol Hepatol 1994;6:599-602.
50. Suarez MS, Cansino JG, Ilizalde CV, et al. Three treatment schemes with colloidal bismuth subcitrate (Q-ULCER) in peptic ulcer with Helicobacter pylori. Arch Med Res 1999;30:55-9.
51. Sung JJ, Chung SC, Ling TKW, et al. One-year follow-up of duodenal ulcers after 1-week triple therapy for Helicobacter pylori. Am J Gastroenterol 1994;89:199-202.
52. Sung JJ, Chung SC, Ling TK, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139-42.
53. Unge P, Gad A, Eriksson K, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993;5:325-31.
54. Van Zanten SJOV, Bradette M, Farley A, et al. The DUMACH study: Eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharm Ther 1999;13:289-95.
55. Wang WM, Chen CY, Jan CM, et al. Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers. J Formos Med Assoc 1993;92:721-4.
56. Wang K, Lin HJ, Chua RT, et al. Omeprazole plus amoxicillin versus triple therapy eradicates Helicobacter pylori in the Chinese with peptic ulcer disease. Chin Med J 1996;57:184-90.
57. Wong BCY, Lam SK, Lai KC, et al. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: A prospective long-term follow-up study. Aliment Pharm Ther 1999;13:303-9.
58. Kleinman L, McIntosh E, Ryan M, et al. Willingness to pay for complete symptom relief of gastroesophageal reflux disease. Arch Intern Med 2002;162:1361-6.
59. Van der Hulst RW, Rauws EA, Koycu B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: A prospective long-term follow-up study. Gastroenterology 1997;113:1082-6.
60. Moore RA. Helicobacter pylori and peptic ulcer. A systematic review of effectiveness and an overview of the economic benefits of implementing what is known to be effective. http://www.jr2.ox.ac.uk/bandolier 1994.
61. Leodolter A, Kulig M, Brasch H, et al. A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharm Ther 2001;15:1949-58.
62. Moayyedi P, Feltbower R, Crocombe W, et al. The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat program. Aliment Pharmacol Ther 2000;14:719-28.
63. O'Brien B, Goeree R, Mohamed AH, et al. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. Arch Intern Med 1995;155:1958-64.
64. Briggs AH, Sculpher MJ, Logan RP, et al. Cost-effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. Br Med J 1996;312:1321-5.
65. Fendrick AM, McCort JT, Chernew ME, et al. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: Clinical and economic effects. Am J Gastroenterol 1997;92:2017-24.
66. Sonnenberg A, Schwartz JS, Cutler AF, et al. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies. Arch Intern Med 1998;158:852-60.
67. Lau J, Ioannidis JPA, Schmidt CH. Summing up evidence: One answer is not always enough. Lancet 1998;351:123-7.
68. Moher D, Cook DJ, Jadad AR, et al. Assessing the quality of reports of randomized trials: Implications for the conduct of meta-analyses. Health Technology Assessment 1999;3:1-106.
69. Spiegel BM, Vakil NM, Ofman JJ. Dyspepsia management in primary care: A decision analysis of competing strategies. Gastroenterology 2002;122:1270-85.
70. Manes G, Mosca S, De Nucci C. High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection. Dig Liver Dis 2001;33:665-70.
71. Vincze A, Karadi O, Hunyady B, et al. One year follow-up of patients after successful helicobacter pylori eradication therapy. J Physiol 2001;95:457-60.
72. McColl KE, Dickson A, El-Nujumi A, et al. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: Impact of gastroesophageal reflux disease. Am J Gastroenterol 2000;95:101-5.
73. Vakil N, Hahn B, McSorley D. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:45-51.
74. Chen TS, Chang FY, Lee SD, et al. Recurrence of H. pylori infection and dyspeptic symptoms after successful eradication in patients cured of duodenal ulcer disease. Hepato-Gastroenterology 1999;46:252-6.
75. McColl KE, el-Nujumi A, Murray LS, et al. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer. Gut 1998;42:618-22.
76. Phull PS, Halliday D, Price AB, et al. Absence of dyspeptic symptoms as a test of Helicobacter pylori eradication. Br Med J 1996;312:349-50.
77. http://www.drugstore.com/products-listed price of one months generic omperazole 20 mg od.